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Abstract  27 
Purpose: To examine the degree to which quantitative aspects of dosage (dose, dose frequency 28 
and total intervention duration) have been examined in intervention studies for children with 29 
developmental language disorder (DLD). Additionally, to establish the optimal quantitative 30 
dosage characteristics for phonology, vocabulary and morpho-syntax outcomes. 31 
Method: This registered review (PROSPERO ID=CRD42017076663) adhered to PRISMA 32 
guidelines. Search terms were included in seven electronic databases. We included peer 33 
reviewed Quasi-experimental, RCT or cohort analytic studies, published in any language 34 
between January 2006 to May 2020. Included papers reported on participants with DLD (M= 35 
3-18 years); oral language interventions with phonology, vocabulary or morpho-syntax 36 
outcomes; and experimental manipulation or statistical analysis of any quantitative aspect of 37 
dosage. Studies were appraised using the Cochrane risk-of-bias tool. 38 
Results: 244 papers reported on oral language interventions with children with DLD in the 39 
domains of interest, 13 focused on experimentally /statistically manipulating quantitative 40 
aspects of dosage. No papers reported phonological outcomes, three vocabulary and eight 41 
morpho-syntax. Dose frequency was the most common characteristic manipulated. 42 
Conclusion: Research is in its infancy and significant further research is required to inform 43 
SLPs in practice. Dosage characteristics are rarely adequately controlled for their individual 44 
effects to be identified. Findings to date suggest that there is a point in vocabulary and 45 
morphosyntax interventions after which there are diminishing returns from additional dosage. 46 
If dose is high (number of learning opportunities within a session) then the literature suggests 47 
that session frequency can be reduced. Frequent, short sessions (2/3x per week; ~2mins) and 48 
less frequent, long sessions (1x per week; ~ 20mins) have yielded the best outcomes when  49 
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composite language measures have been used, however replication and further research is 50 
required before clinicians can confidently integrate these findings into clinical practice.  51 
Introduction 52 
In the 33 years since the publication of the first systematic review of interventions for childhood 53 
speech and language disorders (Nye et al., 1987), there has been sustained growth in both the 54 
number and quality of intervention studies published in the field. The question at that time was 55 
whether or not interventions could have a positive effect on outcomes for children. It is clear 56 
from this and subsequent reviews, meta-analyses and Randomised Controlled Trials (RCTs), 57 
that interventions can and do effect meaningful change for children and young people with 58 
speech, language and communication disorders (Law et al., 2005; 2004; Broomfield & Dodd, 59 
2011; Roberts & Kaiser, 2011). Practitioners can now confidently counsel parents and advise 60 
managers and commissioners of services, that effective interventions exist. However, if 61 
effective and cost-effective services for children with speech, language and communication 62 
disorders are to be delivered and funded, more specific questions must now be addressed. 63 
Crucial to the design of evidence-based services and policy is the issue of dosage: how much 64 
intervention, in which form and at what intensity is required for positive outcomes to be 65 
achieved. Whilst practitioners and services strive to provide evidence-based interventions, 66 
surveys and reviews of practice demonstrate that factors other than current best evidence 67 
influence decisions regarding intervention dosage and delivery. These include available 68 
funding, service configuration and cultures of current ‘custom and practice’ (Brandel & 69 
Froeme-Loeb, 2011; McKean et al., 2019; Ruggero et al., 2012; Sugden et al., 2018). 70 
This study examines and synthesises current evidence regarding optimal intervention dosage 71 
and intensity, with respect to children with Developmental Language Disorder (DLD). DLD 72 
affects approximately 8% of children and is diagnosed in children presenting with persisting 73 
language difficulties which affect their social and educational functioning, and which is not 74 
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caused by another neurobiological condition (Bishop et al., 2017). DLD is one of the most 75 
common neuro-developmental disorders with potentially profound and long-term 76 
consequences, increasing risks of poor outcomes for mental health, education, social inclusion, 77 
and employment. Despite this, services to children with DLD are not universally available 78 
across childhood, at levels sufficient to deliver interventions in the dosages found to be 79 
effective in intervention studies (Law et al., 2019).  80 
Why are issues of dosage important? 81 
The most obvious drivers for research regarding optimal intervention dosage are economic. 82 
More Speech and Language Therapy (SLT) input comes with associated costs (Sciberras et al., 83 
2014) and so there is a need to determine whether increased dosage really does lead to better 84 
outcomes; whether any such relationship is linear such that more is always better, or 85 
curvilinear, where we begin to see diminishing returns above a certain level; and also whether 86 
there is a baseline dosage below which little or no effect can be expected. Finding the optimal 87 
dosage for intervention is also important in terms of the burden placed on children and their 88 
families. Attending speech and language therapy has implications for families’ time and 89 
resources, and so intervention duration and intensity should not be more than needed to attain 90 
the goals of therapy, or so minimal that they effectively waste the time and effort of those 91 
involved.  Where children are pulled out of their classroom for SLT, it is essential that dosage 92 
is such that the benefits of intervention outweigh the costs of missed classroom learning and 93 
of potential stigmatisation associated with SLT attendance. When considering the burden of 94 
interventions on families and children, it is hard not to conclude that delivery of interventions 95 
in dosages so low as to have no chance of effecting change are not only uneconomical but also 96 
unethical.  97 
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Finally, research regarding optimal dosage is vital for commissioners and policy makers to 98 
develop, fund and deliver evidence-based policy and for practitioners, families and individuals 99 
with DLD to advocate for appropriate levels of service provision.  100 
What is ‘dosage’? 101 
Although an intuitively simple construct, dosage in behavioural interventions is a complex 102 
phenomenon to describe and hence to measure. Warren et al. (2007) proposed a list of five 103 
dosage characteristics to describe intervention intensity. Three quantitative components are 104 
dose, dose frequency, and total intervention duration, which can be combined to quantify 105 
cumulative intervention intensity. There is also a qualitative component, dose form.  106 
Dose form refers to the typical tasks or activities (i.e. active ingredients) within which the 107 
teaching episodes are delivered.  108 
• Dose is the number of properly administered teaching episodes during a single 109 
intervention session and has three subcomponents, 110 
o  the average rate of teaching episodes per unit of time 111 
o the length of the intervention session,  112 
o and the distribution/ density of episodes over the session.  113 
• Dose frequency can be defined as the number of intervention sessions per unit of time 114 
(i.e. a day, a week, a month).  115 
• Total intervention duration is the total period of time for which a specified intervention 116 
is provided.  117 
• Finally, cumulative intervention intensity is a product of the previous three 118 
components i.e. dose x dose frequency x total intervention duration.  119 
What is known about optimal intervention dosage for children with DLD?   120 
 121 
Zeng et al. (2012) completed a systematic review to examine the influence of intervention 122 
intensity on outcomes for children with speech and language disorders. Study reporting 123 
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hampered the review, as the authors noted that dosage data is not consistently reported in 124 
intervention studies. In particular, studies rarely included the average rate of teaching episodes 125 
per unit (dose), making it impossible to calculate cumulative intervention intensity. Using 126 
length of each session as a proxy for dose they concluded that there is a non-linear relationship 127 
between dosage and effect size suggesting that intervention volume is not as important as its 128 
quality: more is not necessarily better. 129 
There is contradictory evidence as to the minimum dose required to effect change, with an 130 
average of 6 hours therapy (range 0 – 24, over 6 months- using an intention to treat protocol or 131 
recommendation for review) being linked to greater gains than a wait-list control in a study by 132 
Broomfield and Dodd (2011), and a similar level of input (average 6.2 hours, range 0 – 15, 133 
over 12 months) being associated with no significant difference in a study by Glogowska et al. 134 
(2000). Consideration of study methodology would suggest that Broomfield and Dodd’s 135 
findings may be more robust (e.g. power: N of 703 versus 159; homogeneity of participants; 136 
greater treatment fidelity). However, it is not possible from either study to determine the 137 
optimal dosage for clinically meaningful changes to occur; as Law and Conti-Ramsden, (2000) 138 
note it is highly unlikely that 6 hours of therapy is enough. When it comes to defining optimal 139 
intervention dosage, things become even less clear, as previous research has reported differing 140 
values. In their meta-analyses, Nye et al. (1987) reported that interventions of more than 13 141 
weeks duration were not as effective as interventions with shorter durations i.e. one to 12 142 
weeks, with the highest effect size found for interventions lasting 4-12 weeks. However, Law 143 
et al. (2004) found that interventions lasting for more than 8 weeks seemed more effective than 144 
shorter interventions. Additionally, considering session lengths Nye et al. (1987) reported that 145 
session lengths shorter than 90 minutes yielded higher effect sizes than longer sessions. Jacoby 146 
et al. (2002) studied the number of individual ‘treatment units’ (i.e. 15-minute sessions) needed 147 
to facilitate functional communication improvements in children with articulation and/or 148 
 7 
language disorders. They found that the degree of improvement was correlated with the number 149 
of treatment units (time in therapy). In this study, the odds of improvement increased when the 150 
child received at least 20 hours of therapy. There are a number of potential reasons for these 151 
differing findings.  Therapy outcomes may be particularly important. The complex and 152 
interrelated nature of dosage means that studies rarely manipulate only one element at a time 153 
making causal conclusions difficult.  Furthermore, a number of theories of language acquisition 154 
and/or explanatory theories of DLD posit that vocabulary, phonology and morpho-syntax may 155 
invoke differing learning mechanisms in children, and hence optimal dosage characteristics 156 
may vary across domains (Botting & Marshall, 2017).  157 
Theories of learning and their implications for dosage 158 
Theories of learning that are relevant across domains, in the context of dose and dose frequency 159 
with respect to children with DLD, pertain to how and over what time-period information is 160 
encoded and consolidated. One theory posits that learning is more efficient when the same 161 
number of teaching episodes are distributed over several sessions, than when they are 162 
massed/concentrated into one or a few sessions (see Janiszewski et al., 2003 for meta-analysis 163 
of 93 studies with typical language learners). If treatment sessions are distributed across 164 
different days or weeks, this allows for new information to be re-encoded during each session 165 
and consolidated between sessions. On the other hand, massed practice does not offer the same 166 
opportunity for consolidation following children’s encoding of new information. Children with 167 
DLD have been shown to have encoding difficulties (Alt & Plante, 2006) and require a greater 168 
number of exposures to both vocabulary and syntactic forms than children with typical 169 
development (Cleave et al., 2015; Gray, 2003; Rice et al., 1994). They have also been shown 170 
to have poorer phonological short-term memory and working memory than their typically 171 
developing peers, thereby negatively impacting their memory consolidation. If children’s 172 
primary difficulty is one of encoding, then we would expect that the dose per session or 173 
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cumulative dose may be more important than the dose frequency. If children receive a high 174 
treatment dose, they have the opportunity to encode and re-encode multiple times, thereby 175 
strengthening their initial representation. On the other hand, if consolidation is the more 176 
significant impediment to learning, then we might hypothesize that dose frequency would have 177 
a greater impact on treatment outcomes. Even if the information has only been partly encoded 178 
following initial exposure, it may be that memory consolidation can work incrementally, 179 
building on the encoded representation at each time point.   The processes of encoding new 180 
information and memory consolidation are also very relevant for the timing of outcome 181 
measures. Immediate testing, particularly with respect to probes during treatment, is likely to 182 
measure the child’s encoding ability, whereas delayed testing (post intervention and at follow 183 
up) is tapping the level of consolidation or decay that has occurred. 184 
Current study 185 
Since the publication of the Zeng et al. (2012) review, a number of studies which directly 186 
manipulate aspects of intervention dosage have been published. In order to inform evidence-187 
based service delivery, commissioning and policy, this paper presents a systematic review and 188 
narrative synthesis of intervention studies for children with DLD in which aspects of oral 189 
language intervention dosage are experimentally manipulated, or retrospectively statistically 190 
analysed. The review is the first of a pair completed with similar methodology and focuses on 191 
quantitative aspects of dosage. The focus of the other review is on the qualitative characteristic, 192 
dose form. To increase confidence in the conclusions drawn, the Oxford Centre for Evidence 193 
Based Medicine Hierarchy of evidence was applied and only studies using designs at levels 1, 194 
2 and 3 were included (Systematic Reviews of RCTs, RCTs, Non-randomized controlled 195 
cohorts/follow up designs). Those at levels 4 and 5 (case series, case control and mechanism-196 
based reasoning) were excluded (OCEBM Levels of Evidence Working Group, 2011).  The 197 
review focuses on interventions in which there are outcomes in the domains of phonology, 198 
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vocabulary and morpho-syntax, and reports findings separately to determine whether optimal 199 
dosage characteristics differ across domains.  200 
We addressed the following questions 201 
1) To what degree have the quantitative aspects of dosage (dose, dose frequency and total 202 
intervention duration) been specifically manipulated and compared in intervention 203 
studies and how confident can we be in the study findings? 204 
2) What are the optimal quantitative dosage characteristics for phonology, vocabulary and 205 
morphosyntax outcomes? Do they differ across domains? 206 
3) What gaps remain in the evidence? 207 
Method 208 
This systematic review was registered with PROSPERO (ID=CRD42017076663): and is one 209 
of a series completed as part of European COST Action 1406.   Action 1406 focussed on 210 
understanding intervention and service delivery for children with DLD across Europe and a 211 
number of partner countries. Our methods adhere to PRISMA guidelines for systematic 212 
reviews (Moher et al., 2015). Due to the heterogeneity of the included studies, combining data 213 
in meta-analysis was not appropriate, the review is therefore presented as a narrative synthesis. 214 
Search Procedures 215 
Searches were conducted to identify empirical peer reviewed articles, in any language, that 216 
related to oral language interventions with children with DLD. Due to the adoption of DLD 217 
terminology and criteria being very recent (Bishop et al., 2017), our searches included previous 218 
terminologies used to refer to this group of children or to subgroups within the umbrella of 219 
DLD, such as Specific language impairment or Language impairment. The exact terminology 220 
used in each study were extracted and are presented in Table 1. Seven electronic databases 221 
were used and included Web of Science (Including Medline, SSCI), MEDLINE(PubMed), 222 
ERIC, PsycINFO, Cochrane Library, Scopus, and LLBA. The initial search was limited to peer 223 
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reviewed studies, published between and inclusive of January 2006 to December 2015. Three 224 
updated searches were then completed; the first to include studies published between January 225 
2016 and October 2017; the second between November 2017 and May 2019 and the third 226 
between June 2019 and May 2020. Search terms were developed through discussion between 227 
authors and consultation with a research librarian. The search string is published in our pre-228 
registration (McKean et al. 2017). Reference lists of all papers included on full text and relevant 229 
systematic reviews were also hand searched for any additional papers.  230 
Inclusion / Exclusion criteria 231 
Included papers met the following criteria: 232 
• Research design – either 1) RCTs; 2) Quasi-experimental designs (non-random assignment) 233 
with an element of control; 3) Cohort analytic designs, observational studies in which groups 234 
were assembled according to whether or not they have received the intervention, with control. 235 
• Peer reviewed publication in any language, published between January 2006 - May 2020. 236 
• Participants with a mean age ≥3 years and ≤18 years,  237 
• Participants identified as having a) developmental language disorder or an equivalent term such 238 
as primary language impairment or specific language impairment and b) difficulties on at least 239 
one oral language assessment (vocabulary, morpho-syntax or discourse) falling below 1 SD 240 
below the mean. Those with language impairment secondary to those conditions identified by 241 
CATALISE criteria as precluding a DLD diagnosis (e.g. Autism Spectrum Condition, Learning 242 
Disability), were not included. Those with language difficulties and an ‘associated condition’ 243 
allowed in CATALISE criteria (e.g. ADHD, dyslexia) were included. Children with childhood 244 
apraxia of speech (CAS) were excluded on the basis that their pattern of response to 245 
phonological interventions may differ from those with other disorders (Morgan & Vogel, 246 
2008), in particular with respect to dosage and so their inclusion could potentially bias our 247 
findings regarding dosage effects in DLD.   248 
• Examined an oral language intervention which measured outcomes in the domains of 249 
phonology, vocabulary and/or morpho-syntax  250 
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• Experimentally manipulated or statistically analysed an aspect of either dose, dose frequency 251 
or cumulative intervention intensity, whilst keeping other variables constant.  252 
More detailed definitions of our research design categories and our definition of intervention 253 
are given in our PROSPERO pre-registration (ID=CRD42017076663).    254 
Paper Selection and Reliability of Search Procedures 255 
Stage 1: The initial search formed the basis of several COST Action IS1406 reviews with 256 
differing foci. The aim was to identify papers evaluating interventions for children with DLD 257 
across all language domains (vocabulary, phonology, morpho-syntax and pragmatics). These 258 
papers were initially screened on title and abstract for inclusion/ exclusion based on the criteria 259 
of date, target group, level of evidence (whether there was an element of control included in 260 
the study design) or evaluation of an intervention. Twenty percent were double screened by 261 
two independent reviewers, (CAM & DS for the initial search and CAM & PF for the three 262 
updated searches) using specialist software supporting systematic reviews (EPPI – Reviewer 263 
4). Reliability calculation was undertaken at each stage with an overall agreement rate of 96%. 264 
Disagreements at this and all subsequent stages were resolved through discussion. This stage 265 
yielded 1198 papers. All non-English papers at this and subsequent stages were considered by 266 
either author AKT (who is fluent in a number of languages) or by a native speaker of the 267 
relevant language in the COST Action, and the relevant criteria discussed with PF after 268 
translation. 269 
Stage 2: To identify those specifically relevant to vocabulary, phonology or morpho-syntax 270 
outcomes considered in this review, two independent reviewers (PF and AKT) screened 100% 271 
of the papers included after stage 1 on title and abstract. Agreement rate of 93%. This yielded 272 
698 papers. 273 
Stage 3. Full text screening was completed against the inclusion / exclusion criteria by the same 274 
two independent reviewers. Agreement rate was 94%. 275 
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Stage 4.  Full text screening was then completed on the 244 papers emerging from stage 3 to 276 
identify those with a specific focus on dosage characteristics, which were experimentally 277 
manipulated or statistically analysed, and with research designs at levels 1, 2, or 3 in the Oxford 278 
Centre for Evidence Based Medicine Hierarchy of evidence. Agreement rate at this stage was 279 
97%.  280 
Stage 5. Finally, full text screening was completed on the 39 papers that emerged from stage 4 281 
and only those that focused specifically on dose, dose frequency, intervention duration or total 282 
intervention intensity were included (n =13). See Figure 1 for PRISMA flowchart.  283 
----Insert Figure 1 about here--- 284 
Data Extraction 285 
The first author extracted the following data from the papers and tabulated it in an Excel 286 
spreadsheet: study design (RCT, quasi-experimental, cohort analytical); participant variables 287 
(number, mean age at intervention baseline); treatment detail (intervention context, dose form, 288 
treatment/control targets, dosage manipulation, planned/received dose (both were extracted if 289 
reported), planned /received dose frequency and intervention duration; and outcome measures 290 
(the nature and timing of measures and the main findings)  291 
Risk of Bias 292 
The first and last author (PF and CMK) appraised study quality using the Cochrane Risk of 293 
bias tool for RCTs (Higgins et al., 2011). The tool aims to evaluate Selection bias (random 294 
sequence generation and allocation concealment); Performance bias (blinding of participants 295 
and personnel); detection bias (blinding of outcome assessment); attrition bias (incomplete 296 
outcome data); reporting bias (selective reporting) and other bias deemed important by the 297 
reviewers (for which we included fidelity measures and noted whether a power calculation was 298 
completed). For studies in which the target group or items were not randomized, the two 299 
evaluation categories for selection bias were coded as not applicable. These studies were 300 
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evaluated according to the remaining categories. We assigned risk of bias ratings of high, low 301 
or unclear. Both reviewers rated each article independently and disagreements were resolved 302 
by consensus. The risk of bias assessment for each paper is shown in Figure 2. ----Insert Figure 303 
2 about here--- 304 
Results 305 
Thirty-nine papers reported on studies in which dosage was experimentally or statistically 306 
manipulated and 13 of these focused on the quantitative aspects of dosage.  These 13 papers 307 
came from 8 journals, 9 of which were in the English language and 1 which was in German. 308 
Of the 13 papers, 3 (23%)1 were from the Journal of Speech, language and Hearing Research; 309 
3 (23%) from Language Speech and Hearing Services in schools; 2 (15%) from the American 310 
Journal of Speech-Language pathology; and 1 (8%) from each of the following journals; the 311 
International Journal of Language and communication disorders; the International Journal of 312 
Speech-language Pathology; Child Language Teaching and Therapy; Communication 313 
Disorders Quarterly; and L.O.G.O.S. Interdisziplinair. Eleven of the 13 studies were conducted 314 
in the United States (85%); 1 in the United Kingdom (8%); and 1 in Germany (8%). A total of 315 
481 children with DLD (M = 40.1; SD = 61.3) were represented in the 13 studies. Sample sizes 316 
varied from 12 to 233 children (Med = 25) and children with DLD had an average age range 317 
from 3;11 to 12;01 years. See Table 1 in supplemental materials.  318 
Selection criteria for children with DLD.  319 
The majority of studies identified children as having DLD (or a previously used term such as 320 
Specific language impairment/ Language impairment)  using the following criteria 1) a 321 
composite score of below 1 standard deviation on a standardized language measure such as the 322 
Clinical Evaluation of Language Fundamentals (CELF 4) or the Structured Photographic 323 
Expressive Language Test (SPELT-3) 2) non-verbal IQ scores within 1 standard deviation of 324 
 
1 May not sum exactly 100% due to rounding 
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the norm on a test of cognitive functioning 3) hearing within the normal range (shown by 325 
passing a pure tone hearing screening) and 4) no known neurological, social-emotional or 326 
psychiatric disorders. With respect to the two studies that took place in the community [4,8] 327 
although the language cut point for inclusion was – 1SD the authors point out that on average 328 
the included sample scored more than 2SDs below the mean. The DLD diagnosis in Germany 329 
[9] was different in that it was based on medical history and the participants were required to 330 
have specific language characteristics pertinent to the intervention – such as an MLU of 3 331 
words and a language sample showing no more than 15% of expressions with the verb in the 332 
second position. Three studies had a slightly lower cut-point in relation to cognitive ability i.e. 333 
a standard score of 80 [1] and 75 [6, 7]. No evidence of speech impairment was specified in 3 334 
of the 13 studies.  335 
RQ 1: To what degree have quantitative aspects of dosage been specifically manipulated and 336 
compared in interventions studies and how confident can we be in the study findings? 337 
No studies manipulating quantitative dosage characteristics were identified which focussed on 338 
phonological outcomes in children with DLD. There is therefore no clear evidence regarding 339 
dose, dose frequency, total intervention duration or cumulative treatment intensity in relation 340 
to phonology with this population. In contrast there were 3 studies (23%) specific to 341 
vocabulary, and 8 (62%) specific to morphosyntax. Lastly, there were two studies with 342 
omnibus outcomes (15%) in which dosage was statistically manipulated.  Figure 2 summarises 343 
the risk of bias in each of the studies. Five studies (39%) were RCTs, level 1 in the hierarchy 344 
of evidence and within those RCTs 3 of the 5 focussed on morphology; only 2 studies explicitly 345 
described selected random sequence generation; none of the five described selection allocation 346 
concealment; and none reported on a priori power calculation. Participant numbers in RCTs 347 
were generally small (ranging from 12 to 34 children), raising concerns regarding statistical 348 
power to detect differences. In addition, although RCTs aim to control for differences across 349 
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groups this does not always work with small sample sizes. Of the five RCTs, none recruited 350 
randomly from a larger population, 2 recruited from a single setting, 2 recruited from multiple 351 
settings and one was unclear. Randomization was always with respect to the treatment 352 
condition. Each of the trials were preliminary and included elements of phase 1 and phase 11 353 
trials (Fey & Finestack, 2009). With respect to phase 1, studies aimed to address the core 354 
treatment parameter of intensity, and in relation to phase 11 they examined treatment benefit 355 
across children, preliminary indications of efficacy. Quasi-experimental, (level 2) studies made 356 
up 39% of the papers, with 4 of the 5 focussed on morphology. In broad terms these studies 357 
were non-equivalent group designs although in some studies there was an attempt to match 358 
across variables, such as non-verbal IQ and language scores. Our inclusion criteria ensured an 359 
element of control for all studies.  Detection bias blinding was either not addressed or unclear 360 
in 4 of the 5 studies and similarly there was no reported power calculation for 4 of the 5 studies. 361 
The cohort analytical studies (n= 3; 23%) included two with the same sample [4,9], neither of 362 
which reported explicitly on attrition. Due to the nature of language studies, performance bias 363 
blinding is extremely challenging for all studies. Biases not present in the majority of studies 364 
were attrition bias; selective reporting; and other fidelity measures. Analysis of the publication 365 
dates for the included studies show that the majority have been published in the previous 5 366 
years (2016 – 2020 n = 8 (62%); 2011 – 2015 n = 3 (23%); 2005 – 2010 inclusive n = 2 (15%)) 367 
demonstrating an increasing focus and interest in this important issue, and a growing evidence 368 
resource to inform practice.  369 
RQ 2. What are the optimal dosage characteristics for phonology, vocabulary and 370 
morphosyntax outcomes? Do they differ across domains? And RQ 3. What gaps remain in the 371 
evidence?  372 
The following provides a narrative summary of the findings of the papers identified, organised 373 
by outcome (Vocabulary, Morpho-syntax, Phonology, Omnibus Measure). In each section we 374 
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report on each of Warren and colleagues quantitative dosage components in turn (dose, dose 375 
frequency, total intervention duration and cumulative treatment intensity), identifying whether 376 
evidence exists, summarising the findings and describing the level of confidence in those 377 
findings. Table 1 also summarises the data extracted from the papers.  378 
Vocabulary 379 
For this domain studies manipulating dose (n = 1) [Study 12 – Table 1]2,  and dose frequency 380 
(n = 2) [8, 13] were identified but none were found for total intervention duration or cumulative 381 
intervention intensity. 382 
Dose: number of properly administered teaching episodes during a single session 383 
The issue of optimal number of exposures, with respect to new word learning, is addressed by 384 
Storkel and colleagues in their 2017 paper [12], in the context of interactive book reading using 385 
a novel escalation design methodology. Twenty-seven children with DLD (M = 5;08 years) 386 
were randomly assigned to one of four word learning treatment intensities: 12, 24, 36, or 48 387 
cumulative exposures. Children heard each target word in a shared book-reading context, 388 
followed by its definition, the use of the target word in a supportive context sentence, and lastly 389 
they were given a synonym of each target word. Target words included nouns, verbs and 390 
adjectives and word learning was assessed through a definition task and a naming task. The 391 
dose per session was either 3, 4, or 6 depending on the treatment intensity. For example, in the 392 
case of 24 cumulative exposures, the target word was repeated 4 times in each book and the 393 
book was read 6 times over the course of the intervention. Based on the word definition 394 
outcome (administered immediately post intervention), no children learned the target words 395 
following 12 exposures. At 36 exposures 43% of children with DLD responded to treatment, 396 
while at 48 exposures fewer children were responding (29%). Diminishing returns were also 397 
evident, when using the average number of words with correct definitions in the last block as 398 
 
2 Numbers in square brackets indicate the study number in Summary Table 1 
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the outcome measure, for each treatment intensity. Children showed the ability to define the 399 
most words (n=5) following 36 exposures and word learning began to diminish at 48 exposures. 400 
In addition, results from the naming task indicated 36 exposures to be the optimal dose (with 401 
86% of children responding). A decrease in treatment response was again evident as the 402 
number of exposures increased to 48. The finding that children’s optimal performance was 403 
following 36 exposures supports the theory that there is a critical minimum number of 404 
exposures required to allow adequate encoding of words to occur. On the other hand, 405 
diminishing returns at 48 exposures may be in keeping with deficient-processing theories of 406 
learning, which suggest that learning effectiveness is dependent on the degree of attention 407 
directed towards what is being learned. A reduction in attention is thought to occur as what is 408 
being learned becomes overly familiar, and while this has previously been discussed in relation 409 
to massed practice (Cepeda et al., 2006), it could also occur in the context of too many word 410 
exposures within a given time period.  411 
While this study is highly innovative, in the application of an escalation design to the field of 412 
language learning, there are a number of points to note with respect to dosage. The number of 413 
treatment sessions ranged between 10 and 20 and were given 2 to 3 times a week. Therefore, 414 
the total intervention duration is a confound as it was not constant for each dose. It is also 415 
noteworthy that children’s response to treatment was very low at all exposures, when using the 416 
definition task as a measurement of learning. Only 43% of children responded at optimal 417 
dosage and only 5 treatment words were correctly defined. A more optimistic result was 418 
evident using the naming task as the outcome measure, with 86% of children responding at 419 
optimal dose and 60% responding at a minimum of 12 exposures. The authors posit that 420 
semantic knowledge is measured by the definition task and that the naming task is a measure 421 
of phonology. We suggest this may be an overly conservative approach to the measurement of 422 
semantic knowledge and that word definitions are, perhaps the pinnacle of semantic 423 
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knowledge. More graded outcome measures, sensitive to differing levels of semantic learning, 424 
such as the children’s ability to provide a synonym (a measure included in the study), could 425 
perhaps have yielded different results. It is interesting to contrast this finding with that of 426 
Aguilar et al. (2018), who manipulated dose form rather than dose in their word learning study. 427 
Aguilar and colleagues found that with high variability in the referent presented, preschool 428 
children with DLD had the ability to learn 3 new words having been exposed to them 18 times 429 
over 3 sessions and asked to name the items once per session.  However, learning was measured 430 
through a comprehension probe in the Aguilar study, a task significantly less challenging than 431 
the definition probes and naming tasks used by Storkel et al. (2017). In addition, in contrast to 432 
Storkel et al (2017) where the outcomes were administered immediately post intervention, the 433 
Aguilar retention outcome measure was administered at follow up (6 weeks post intervention), 434 
allowing for a consolidation period which may have facilitated word-learning.  435 
Dose Frequency: number of sessions over a given time frame 436 
Riches et al. (2005) [8] investigated the effect of dose (number of word exposures) and dose 437 
frequency (spacing/ period between exposures) on novel verb learning in children with DLD. 438 
The study was based on the premise that distributed learning is more efficient than a massed 439 
approach. Twenty-four children with DLD (M = 5;06 years) and 24 language matched control 440 
children were taught four novel verbs, using a dual morphological frame (Look its dacking, see 441 
it dacks) modelled through play activities. The manipulation of the number of exposures along 442 
with the spacing of the treatment sessions resulted in four experimental conditions 1) massed 443 
12, with 12 exposures on a single day; 2) massed 18 with 18 exposures on a single day; 3) 444 
spaced 12, with 12 exposures spread over 4 days (3 each day); 4) spaced 18, with 18 exposures 445 
spread over 4 days (either 4 or 5 each day). Outcome measures were carried out directly 446 
following, and one week post intervention, and included an action probe (what does it do? can 447 
you show me?); a production probe (what’s it doing?, can you tell me?); and a comprehension 448 
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probe (from a choice of 3 objects) which one was verbing?.  Post-test measures showed that 449 
children with DLD benefitted from a greater number of exposures to novel verbs with respect 450 
to comprehension. However, based on production the spacing effect was greater and more 451 
significant than the effect of the number of exposures i.e. children had better learning after 12 452 
presentations when the exposures were spaced, than after 18 presentations when the exposures 453 
were massed. It is important to highlight a number of points in relation to this study. Firstly, 454 
the outcome measures administered were not blind, and were designed to assess 455 
comprehension and expression at a single word level. In addition, results are based on 456 
children’s learning of a very small number of verbs (n = 4). Furthermore, the authors 457 
acknowledge that because each verb label was linked to a single object, we cannot assume that 458 
following 12 or 18 exposures, the children developed a generalized representation of each verb 459 
meaning. Although the cumulative treatment intensity is equivalent across some conditions, 460 
the massed presentations differ from the spaced presentation on both dose and dose frequency, 461 
making the relative contribution of each dosage variable on children’s performance difficult to 462 
extract. In addition, whilst highlighting the potential of manipulating spacing effects for 463 
positive gains, the study sheds little light on optimally spaced learning intervals or optimal 464 
number of exposures with respect to word learning in children with DLD.  465 
Storkel et al., (2019) built on this work in their examination of whether different combinations 466 
of dose and dose frequency, (while keeping treatment intensity constant) influenced the ability 467 
of kindergarten children with DLD to learn new words in an interactive book reading context. 468 
Children (between 5;0 and 6;02 years of age) were give 36 exposures to two word sets, 60 469 
words in total consisting of nouns, verbs and adjectives. For the first word set a 6 dose x 6 dose 470 
frequency format was used with all children. For the second word set children were randomly 471 
assigned to one of two conditions, either 4 dose x 9 dose frequency or 9 dose x 4 dose 472 
frequency, while controlling for order effects.  As in their 2017 study, children’s learning was 473 
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measured through a word definition task, but in contrast to their previous study outcome 474 
measures were administered at two time points post treatment (an average of 5 days and 21 475 
days post) and were also tracked during treatment. This was an important aspect of the study 476 
as it revealed that children learned more words during treatment (an average of 10) than they 477 
retained after treatment was withdrawn (an average of 4 words). Only 40% of the words that 478 
were correctly defined at the end of treatment were retained 5 /6 days later and only 30% of 479 
words were retained at the 21 day timepoint. Word learning was however consistent with their 480 
previous study, in that children defined an average of 4 -5 words correctly immediately post 481 
intervention at this exposure level. The drop in word learning calls into question our previous 482 
suggestion that perhaps the word learning advantage shown in the study by Aguilar and 483 
colleagues (2018) was due to the timing of the post intervention outcome measure (6 weeks 484 
post), and that this potentially served as a consolidation period. Results from Storkel et al., 485 
(2019) suggest that the delayed outcome measure revealed decay rather than consolidation.  486 
With respect to treatment scheduling, the manipulation of dose and dose frequency while 487 
maintaining 36 exposures in both conditions, did not result in differences in word learning 488 
outcomes.  This finding suggests that it is the overall dose (number of exposures) that has 489 
greater impact on children’s word-learning than the frequency of the treatment schedule. It is 490 
also in keeping with that reported by Bellon-Harn (2012), Meyers-Denman et al. (2016) and 491 
Balthazar and Scott (2018) (presented later in this review) with respect to morphosyntax, all of 492 
whom reported no learning advantage for a spaced rather than a more concentrated treatment 493 
schedule, when overall dose is controlled .  494 
 495 
Morpho-syntax. 496 
Dose: number of properly administered teaching episodes during a single session 497 
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Only two studies with morphosyntax outcomes included in the review, manipulated dose. 498 
Proctor-Williams and Fey (2007) [7] investigated the effect of three recast densities of novel 499 
irregular past tense verbs on spontaneous conversational productions in two groups of children. 500 
Recasts were provided in the context of a child-led, play based activity and were defined as 501 
“immediate adult responses to child utterances, that repeat some of the child’s words and 502 
correct or modify the morphologic or syntactic form of the child’s prior utterance, while 503 
maintaining the central meaning of the child’s production” (Proctor-Williams & Fey, 2007, p. 504 
1029). Children with DLD  (between 7 and 8 years) and language matched typically developing 505 
children (5-6 years) were exposed to recasts of six novel verbs, at a conversation level density 506 
(.19 per minute), at an intervention level density (.47 per minute) or no recasts, over a period 507 
of 5 sessions. The recast exemplars were distributed equally across the 6 verbs i.e. three in the 508 
low-density recast condition and three in the high-density recast condition. Low density 509 
recasting translated as 2 per verb in each of the five sessions (30 recasts) and high density as 5 510 
per verb in sessions 4 and 5 only (30 recasts). Therefore while dose per session was 511 
manipulated, total dose was equal across high and low density conditions. Cumulative learning 512 
was measured as the number of correct elicited irregular past tense verb productions, directly 513 
post intervention.  514 
Contrary to the authors’ expectations, the children with DLD did not improve their production 515 
accuracy at higher intervention-like recast densities, however the sample size was small ( n = 516 
13). It may also be that difference in dose density was not sufficient to yield a difference in 517 
children’s verb learning across only five sessions or that high density recasting was not high 518 
enough to effect change. We note that the effective density of recasting reported in the Meyers-519 
Denman (2016) study (see below), is higher than that reported here (1.25 per minute v’s .47 520 
per minute). It might also be the case that an equal total dose over the course of the intervention, 521 
reduces the likelihood of significant differences emerging when manipulating dose per session, 522 
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particularly over such a short intervention duration.  It is also noteworthy that for both high 523 
and low density conditions, the total dose is only 30 recasts. This is in stark contrast to the 524 
Meyers-Denman study in which the treatment duration was equivalent (150 minutes) but the 525 
total dose was considerably higher, at 125 recasts. It is also unfortunate that the distribution of 526 
the five intervention sessions was not controlled, which resulted in a substantial range in total 527 
intervention duration (4 to 44 days). Interestingly, when the authors tested the relationship 528 
between length of time, in days, that it took to complete the five sessions and accuracy of past 529 
tense productions in both the low- and high-density conditions the results indicated that the 530 
longer that children were in the experiment, the less accurately they produced the verbs. 531 
Following on from this they investigated whether a gap of 5 days or more between any of the 532 
sessions affected the children’s accuracy of spontaneous productions and found that it did not. 533 
The impact of recasting is further complicated by the fact that children were given at least 5 534 
opportunities to produce each of the irregular past tense verbs in each session regardless of 535 
density condition. Children’s production levels were therefore similar across conditions and 536 
may have gone some way towards reducing the effect of recasting input on their production 537 
outcomes.  538 
Dose: the distribution/ density of episodes within the session. 539 
Building on the work by Proctor -Williams and Fey a more recent study carried out by Plante 540 
and colleagues (2019) [13] reported on within-session manipulation of the dose density of 541 
enhanced conversational recasting. An additional study distinction was that Plante and 542 
colleagues kept overall intervention duration constant. Twenty children with DLD (4 – 5;11 543 
years) were exposed to 24 unique recasts of different morphological forms per session. Recasts 544 
were given in the context of dialogic book reading and free play activities. Treatment took 545 
place 5 days a week for 5 weeks and targets included -ed, 3rd person – s, Aux  is and possessive.   546 
Half of the group heard the recasts over a 30 minute period (1 recast every 1.25 minutes) and 547 
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the other half heard them over a 15 minute period (1 recast every 38s) while maintaining 548 
session length at 30 minutes. The study was designed to ascertain which of the two treatments 549 
was more effective and efficient and how many children generalised their targets in that 550 
timeframe. Children’s learning was measured through the use of generalisation and retention 551 
morpheme probes. The former were administered before each Monday, Wednesday and Friday 552 
session and the latter were given 6 weeks post intervention. Results indicated that the majority 553 
of children showed a strong treatment effect.  However there were no significant differences 554 
between the two treatment conditions on any of the outcome measures (probe or spontaneous 555 
performance, number of treatment responders, follow up performance). In addition there was 556 
a significant relationship between children’s performance at the end of treatment and at follow 557 
up. The authors conclude that within-session high density dose delivery does not offer any 558 
advantage over a lower density delivery, if dose and overall intervention duration are constant. 559 
However, the sample size was again small (n = 10). They also note that although children 560 
retained the gains that they made in treatment they did not show any independent improvement 561 
in target morpheme use following treatment. Findings from this study differed from Proctor-562 
Williams and Fey (2007) in that the treatment itself was effective but given the overall dose 563 
differences (30 recasts v’s between 528 – 600) this is not surprising. An important difference 564 
between the two studies was how the dose density manipulation was implemented. In Proctor-565 
Williams and Fey (2007) the low density condition was distributed across the 5 sessions but 566 
the high density condition was implemented in sessions 4 and 5 only. Therefore the density 567 
manipulation was achieved by altering the number of sessions in which the recasts were given 568 
(2x5 sessions, 5x2 sessions) and as result dose frequency was a confound. In contrast, Plante 569 
and colleagues (2019) altered the session length in which an equal number of recasts were 570 
given (24 recasts in 15 minutes v’s 24 recasts in 30 minutes) and this was constant across all 571 
sessions. Despite these differences both studies showed no differences between the high and 572 
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low density groups when dose was constant. As previously stated, it may have been the case 573 
that the dose was too low in the Proctor-Williams study to have an effect and to reveal any 574 
differences. In contrast Plante and colleagues (2019) implemented a high dose which resulted 575 
in a strong treatment effect but even then no differences emerged. These findings support the 576 
premise that the within-session dose maybe more important in treatment effectiveness than the 577 
session length during which the doses are given, in the context of an equivalent overall 578 
intervention duration. However, further research with larger samples is needed to validate this 579 
finding. 580 
Dose Frequency: number of sessions over a given time frame 581 
Dose frequency was manipulated in 5 of the 8 studies within the morphosyntax domain. Bellon-582 
Harn and colleagues (2012) [2] reported on a study in which they examined the effect of 583 
different dose frequencies on the morphosyntactic abilities of preschool children with DLD (M 584 
= 4.61 years). Children were enrolled into either a concentrated (4 times a week for 6 weeks) 585 
or spaced treatment schedule (twice a week for 12 weeks) in which the dose, dose form, total 586 
number of intervention sessions and so total number of treatment hours (8 hours) were kept 587 
constant. However total intervention duration was not controlled. Using books as the stimuli, 588 
the therapy was described as a ‘scaffolded language intervention’ in which techniques such as 589 
expansions, cloze procedures and models were integrated, with an implicit method of 590 
instruction. Baseline and immediately post-treatment measures were taken using language 591 
sample analysis and probes designed to elicit targets (such as the use of auxiliary, copula, third 592 
person singular 3s). While the authors report positive outcomes following both treatment 593 
schedules, there were no differences in how children performed in either the concentrated or 594 
spaced treatments. This result is not consistent with previous literature in relation to typical 595 
language learners (Ambridge et al., 2006) or children with DLD (Desmottes et al., 2017), 596 
however the sample size is particularly small (6 per group) and consequently these results 597 
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should be interpreted with some caution.  It is also worth noting that there is considerable 598 
variation across studies as to what is considered spaced or concentrated in treatment delivery 599 
and how this interacts with the total duration of the intervention. Indeed, even the more 600 
concentrated treatment in this study is delivered over a six-week period. In addition it is 601 
noteworthy that although the authors suggest that dose is kept constant in this study, they 602 
acknowledge that in a scaffolded-language therapy, there is no predetermined script or target. 603 
As a result, dose was not closely controlled i.e. the frequency of linguistic forms within each 604 
cloze procedure, expansion, and model. The authors suggest that dose for both treatment 605 
schedules was high and may therefore mask any dose frequency effect. It may also be the case 606 
that a total of 8 hours of intervention, which was constant across conditions, was not so lengthy 607 
as to reach the point of diminishing returns, which would potentially result in a smaller effect 608 
for the more frequent schedule. 609 
The second study in which dose frequency was manipulated with respect to morphosyntax, was 610 
carried out by Smith-Lock and colleagues (2013) [11]. The study (which included a larger 611 
sample than that by Bellon-Harn (2012)) compared the effectiveness of two different dose 612 
frequencies in relation to a school-based treatment of expressive grammar. Five-year old 613 
children with DLD were assigned to either 8 one-hour sessions of treatment given over an 8-614 
week period (a spaced treatment), or 8 one-hour sessions given over an 8-day period (a 615 
concentrated treatment). Once again total intervention duration was not controlled. Therapeutic 616 
techniques were integrated into naturalistic play sessions and included explicit instruction, 617 
focused stimulation, recasting and imitation. Treatment targets were individualised and 618 
included accurate use of past and present tense, pronouns and possessives. Learning was 619 
measured on The Grammar Elicitation Test (Smith-Lock et al., 2013) immediately and 8 weeks 620 
post intervention. While results showed significant improvement in the group that received the 621 
spaced treatment, (relative to the same time period prior to treatment), this was not the case for 622 
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the concentrated treatment group. Single-subject analyses indicated that 46% of children who 623 
received the spaced schedule and 17% of those who received the concentrated schedule showed 624 
a significant treatment effect. This result is in keeping with previous findings indicating 625 
advantages for spaced learning but is contrary to results by Bellon-Harn and colleagues (2012). 626 
Of interest is the fact that the number of therapy hours is equivalent for both studies, however, 627 
in addition to the sample size, a notable difference between the two studies is the total 628 
intervention duration. In Smith-Lock et al. (2013) the concentrated intervention takes place 629 
over a relatively short period (8 days). The spaced intervention duration (8 weeks) is however 630 
quite similar to the concentrated intervention duration in the Bellon-Harn (2012) study (6 631 
weeks). We might suppose that, given a total number of therapy hours that is effective and 632 
equal in both conditions, differences only emerge between spaced and concentrated treatment 633 
schedules for children with DLD, when the time frame between the beginning and end of the 634 
treatment is significantly shorter for one condition than the other (e.g. one-week v’s 8 weeks). 635 
It is also the case that while Smith-Locke and colleagues (2013) provided teachers with scripts 636 
and detailed activity plans, dose was not controlled for in this study. Research suggests that 637 
dose frequency effects (i.e. number of sessions) can be mitigated if dose per session is high 638 
(Fey et al. 2013) but the authors do not give us any sense of dose in this study. Additionally, 639 
there are a number of treatment techniques used in both aforementioned studies, such that dose 640 
in relation to each technique is likely to be somewhat diluted and to vary between each 641 
treatment session.  642 
Meyers-Denman and colleagues (2016) [5] is the third included study to examine the effects 643 
of treatment dose frequency on grammatical morpheme remediation in young children with 644 
DLD. Again the sample size was small at eight per group. Using enhanced conversational 645 
recasts, treatment was given in both concentrated (3 x 10 minute sessions within a 4 hour 646 
period, 5 days a week) and spaced conditions (1 x 30 min session 5 times a week). The 647 
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concentrated condition resulted in 15 ten-minute sessions, while the spaced condition resulted 648 
in 5 thirty-minute sessions. Specifically, with respect to dosage, a significant difference 649 
between this study and that by Bellon-Harn (2012) was, regardless of whether treatment was 650 
administered in the concentrated or spaced condition, the treatment dose (24 conversational 651 
recasts per day) rate of delivery (one recast every 1.25 min), total intervention hours (2 ½ 652 
hours) and total intervention duration were controlled. Children’s learning was measured 653 
through a play-based generalisation probe, in which they were required to use the target 654 
morphemes with untreated lexical items. Pre- post- assessments revealed a significant 655 
improvement in morpheme production in both dose frequencies, with no change in untreated 656 
morpheme use. There were however no differences in the effect of treatment for the 657 
concentrated or spaced conditions. The authors conclude that enhanced conversational recast 658 
treatment can produce positive results in a short period of time for children with DLD. This 659 
study appears to lend further support to the idea that if the dose itself is high, in this case one 660 
recast every 1.25 minutes, it facilitates more effective encoding and dose frequency can be 661 
reduced. One could argue that both treatment frequencies were relatively high as treatment was 662 
given daily in both conditions. On the other hand, given the small sample size it may be that 663 
there was not sufficient statistical power to detect differences between the two conditions. In 664 
any case, optimal dose frequency relative to dose, has yet to be established.  665 
In a more recent study Balthazar and Scott (2018) [1] manipulated dose frequency with respect 666 
to the treatment of complex sentences in older children with DLD (10 – 14 years). Adverbial, 667 
object complement and relative clauses were taught following a once or twice weekly treatment 668 
protocol. Total intervention duration was nine weeks and session length ranged between 40 669 
and 60 minutes, resulting in total intervention time of 6-9 hours for the once weekly condition 670 
and 12-18 hours for the twice weekly condition. Importantly, dose was kept constant at a 671 
planned rate of 30 stimuli per session and an actual rate of 26 items per session (236 in total) 672 
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in the once weekly condition and 28 items per session (502 items in total) in the twice weekly 673 
condition. Stimuli presentation was through modelling, repetition and manipulation of a 674 
complex sentence with scaffolding and clinician feedback. Primary outcome measures were 675 
sentence probes administered before, during and after treatment as well as standardized 676 
language tasks reflecting a broad range of oral and written language. Interestingly while 677 
treatment was effective as measured by the sentence production probes, there was no advantage 678 
for the higher dosage group on any oral language measure. This finding was contrary to the 679 
authors’ hypothesis and they suggest a number of possible explanations for this result: given 680 
that 3 sessions were devoted to each sentence type, even in the once weekly group, there may 681 
have been no advantage to the additional sessions; they acknowledge that treatment 682 
maintenance was not examined; and they question whether the difference in the two dose 683 
frequencies was sufficient to yield a difference. We suggest that the findings of this study are 684 
in keeping with previous studies and support the notion that high dose reduces the need for 685 
high intervention frequency. However, it is important to consider maintenance effects.  686 
An additional study in which dose frequency was statistically analysed in the treatment of 687 
complex syntax was carried out by Siegmüller and colleagues (2017) [10]. Intervention 688 
outcomes were children’s ability to use subordinate clause structures. Intervention dose form 689 
was implicit and carried out in 6 steps which included 1) intensive modelling of a) verbs and 690 
their associated arguments and b) different grammatical subcomponents of the sentence; 2) 691 
questions eliciting the production of the main clause 3) modelling expansions of the main 692 
clause to subordinate clause structures. Children were assigned to different steps depending on 693 
their pre-test performance and treatment was discontinued when the child reached step 5 694 
(showed the ability to use subordinate clauses). To analyse the effects of dose frequency on the 695 
outcome, the children were divided into two groups: those who had therapy once weekly and 696 
those who had therapy twice weekly. The aim was to establish the effect of dose frequency on 697 
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how many sessions the children needed to reach the intervention goal. The maximum number 698 
of intervention sessions was 22. In support of a spacing effect advantage, the results showed 699 
that the children who received less intensive treatment (once weekly), needed fewer sessions 700 
to achieve the therapy goals than the children who received more intensive treatment. When 701 
analysing the effect of age on achieving the intervention outcome, a significant moderate 702 
correlation was found between age and number of sessions. To study this further, the children 703 
were divided into two groups: young and old. There was a significant difference between the 704 
groups in the number of sessions needed with younger children requiring fewer sessions. The 705 
authors suggest that younger children might react faster and more easily to intervention than 706 
older children. However, given the fact that we have no information on dose (of each dose 707 
form) it is difficult to draw strong conclusions from this study. As was the case with work 708 
already described (Bellon-Harn, 2012; Meyers-Denman et al., 2016) if the dose of each aspect 709 
of the treatment protocol was high then this may have negated any benefits of a more frequent 710 
intervention. On the contrary, the participant numbers are greater in this study,  therefore 711 
revealing a spacing advantage which perhaps could not be detected with smaller sample sizes.  712 
Total Intervention Duration 713 
Only one study was identified for inclusion in the review in which total intervention duration 714 
was manipulated. Bellon-Harn and colleagues (2014) [3] examined the effects of interactive 715 
storybook reading on children’s use of microstructure elements within language samples. The 716 
study included 12 preschool children with DLD (M = 4.63 and 4.78 years) randomly assigned 717 
to two intervention durations. In one intervention children received 42 sessions across 14 weeks 718 
and in the other they received 24 sessions across 6 weeks. As a result  dose frequency (although 719 
not identical) was minimally different (3 v’s 4 times a week), while there was a considerable 720 
difference in total intervention duration. However, keeping dose frequency fairly similar, while 721 
manipulating the total intervention duration necessitates a considerable difference in the total 722 
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number of intervention sessions per group (almost double), which is also likely to translate into 723 
dose differences (unless intentionally controlled for). The authors do not provide specific dose 724 
information and we can therefore assume dose differences. The outcomes of interest were the 725 
frequency with which children used co-ordinate and sub-ordinate clauses as well as the number 726 
of words within clauses. Although results indicated positive outcomes, there were no group 727 
differences between those who received 24 sessions v’s those who received double this amount 728 
of treatment. The authors suggest that gains in narrative microstructure elements are obtained 729 
with less total treatment time, although it is worth noting that the treatment frequency for both 730 
groups was intense, at 3 to 4 times weekly. It would also be interesting to replicate this finding 731 
while controlling for dose and with a larger sample size. It may have been the case that the 732 
dose per session was sufficiently high that the longer intervention duration served no 733 
advantage. This would support the premise that if dose is high not only frequency but total 734 
intervention duration can be reduced. Again it is important to temper our interpretation based 735 
on the very small sample size included in the study. Previous findings by Fey et al., (2013) in 736 
relation to toddlers with intellectual disabilities suggest that increases in treatment frequency 737 
are only advantageous when dose is decreased, perhaps this is also the case in relation to total 738 
intervention duration and children with DLD. As previously discussed with respect to 739 
diminishing returns in word learning a lack of advantage for the longer morphosyntax 740 
intervention is also in keeping with deficient-processing theories of learning (Cepeda et al,. 741 
2006), with a suggested reduction in children’s attention levels, when what is being learned 742 
becomes overly familiar, in a very lengthy intervention. 743 
Omnibus outcomes 744 
Two further papers investigated how dosage characteristics interact to contribute to children’s 745 
global language outcomes [4, 9]. These papers are based on a unique study that used data from 746 
a large clinically identified sample of children with DLD (n = 233), who were receiving 747 
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language treatment within the U.S. public schools system, over an academic year. Natural 748 
variations in treatment intensity data, allowed the authors to examine the impact of different 749 
aspects of dosage on children’s language outcomes, as well as the extent to which treatment 750 
outcomes vary as a function of one or more dosage parameters. Treatment centred on one of 9 751 
language focused-targets and outcomes were the CELF-4 (Semel et al., 2003) core language 752 
scores and the picture vocabulary subtest from the Woodcock Johnson III Tests of 753 
Achievement (Woodcock et al., 2001). It is important to note that in both papers the term dose 754 
is defined and operationalised differently to Warren et al., (2007). Here it is defined as the total 755 
amount of time spent addressing any one of nine language-focused targets, in contrast with the 756 
now more usual definition of the number of administered teaching episodes in a given 757 
intervention session. Hence it is a proxy measure with less specificity and accuracy than a 758 
measure of dose and it precludes a clear definition of dose form. On the other hand, this 759 
approach allows an examination of dosage effects in a much larger sample than found in other 760 
intervention studies and scrutinises dosage schedules used in real-world clinical contexts. 761 
Using this approach Schmitt and colleagues (2016) [9] examined the extent to which dose, dose 762 
frequency, and the interplay between the two were associated with language gains over the 763 
school year. Using structured equation modelling the results showed that children receiving 764 
low dose /high frequency (intervention sessions of approximately 2 minutes, at a rate of  2 to 765 
3 times per week), or high dose / low frequency (intervention sessions of approximately 20 766 
minutes, at a rate of 1 per week or fortnight) had better outcomes than those receiving high 767 
frequency/ high dose (20 minutes,  2/3 times weekly), high frequency/ average dose (12 768 
minutes, 2/3 times weekly) or low frequency/ low dose treatment (2 minutes, 1 per week or 769 
fortnight). It must be noted when considering clinical application that the total intervention 770 
duration here was a school year and not discrete ‘blocks’ of therapy found in many healthcare 771 
systems (McKean et al., 2019). Therefore both ‘optimal’ conditions have relatively high total 772 
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intervention hours (low dose/high frequency: 2mins x 3 sessions x 28 weeks  = 168 minutes (2 773 
hours 48 minutes); high dose/low frequency: 20 minutes x 1 session x 28 weeks = 560 minutes 774 
(9 hours 20 minutes per year).  775 
Justice and colleagues (2017) [4] aimed to make recommendations about the quantity of 776 
treatment required to achieve the optimal amount of language gain, for children with DLD 777 
using this same dataset. Outcomes were retrospectively analysed with respect to dose, dose 778 
frequency (intensity) and cumulative intensity of therapy. Multi-level modelling allowed the 779 
authors to predict language gains from each dosage parameter and regression weighting guided 780 
a recommended amount of treatment. The process allowed the authors to develop an 781 
empirically derived equation/ algorithm, for use by SLP’s to calculate optimal language 782 
outcomes (defined as an increase of .6SD units). Therefore if a clinician knows the session 783 
frequency (e.g. once weekly) and number of weeks s/he can work with a child over the course 784 
of the school year (e.g. 25), using baseline language scores and .6SD as the desired amount of 785 
change, the algorithm can identify the amount of time that should be spent working on language 786 
skills within each of those 25 sessions. Because baseline language scores are used, the 787 
algorithm which is highly innovative, takes account of the severity of the disorder and provides 788 
therapists with a scientific alternative to making decisions about treatment, rather than those 789 
based on caseload size or common practice. Additionally, by manipulating the session 790 
frequency and the amount of time spent on a given language goal, therapists can also determine 791 
the degree of spacing both within and between sessions, in relation to what is being learned. 792 
With respect to limitations, the authors acknowledge that the algorithms are based on 793 
correlational data and cannot therefore be interpreted causally.  We also do not know how 794 
dosage interacts with SLP decision making and whether the schedule and its relative success 795 
was influenced by therapy goals which may be more suited to one schedule than another (e.g. 796 
past tense -ed versus narrative macro-structure). In addition, although the diversity of goals 797 
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and SLP practice in the schools does suggest that a range of dose forms can be effective, the 798 
ways in which targets were addressed by clinicians is likely to have varied considerably. 799 
Finally, there is a need to better understand interactions between child-level factors such as 800 
language severity and treatment intensity. The literature is unclear regarding whether children 801 
with more severe DLD might benefit from higher frequency interventions or from those in 802 
which learning opportunities are more spaced, thereby facilitating consolidation and enhanced 803 
attention. 804 
Discussion  805 
In this study we aimed to ascertain to what degree the quantitative aspects of dosage have been 806 
specifically manipulated in intervention studies with children with DLD, in which there were, 807 
phonology, vocabulary or morphosyntax outcomes. In addition, we aimed to identify optimal 808 
quantitative dosage characteristics in each of these domains; to highlight gaps in the literature; 809 
and difficulties in interpreting the evidence. The dominant finding of the review is the lack of 810 
intervention studies across domains, in which quantitative aspects of dosage have been 811 
experimentally or statistically manipulated for children with DLD. In addition, a number of 812 
studies included in the review have been carried out with particularly small sample sizes, 813 
causing us to call into question the validity of these findings. Consequently, there is a 814 
significant need for further research to inform clinical practice. Significantly, there were no 815 
studies with phonological outcomes in this population of children in which quantitative aspects 816 
of dosage were manipulated. It is possible that the literature relating to children with Speech 817 
Sound Disorder (SSD) can be directly applied to DLD. However, this has not been tested and, 818 
given the meta-linguistic skills and abstract concepts invoked in many phonological 819 
interventions it would seem likely that modifications in dosage and/or other aspects of the 820 
interventions would be required and should be tested in empirical studies. Given high 821 
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comorbidity between DLD and SSD such work would likely have significant clinical impact 822 
(Eadie et al., 2014).   823 
Vocabulary: The finding that there were only three studies in the vocabulary domain, in which 824 
quantitative aspects of dosage were manipulated, again highlights the dearth of research in this 825 
area. Hence there is limited evidence on which practitioners can draw, to inform the 826 
implementation of interventions and advise managers and policy makers regarding optimal 827 
dosage. The work by Storkel and colleagues (2017), has been both pioneering in its use of an 828 
escalation design, and unique in showing diminishing benefits following a specific number of 829 
word exposures. However, in many ways this important work represents a starting point from 830 
which to grow research in this domain. Given that frequency and total intervention duration 831 
were not constant for each dose, further work is required to determine whether this finding is 832 
replicated under constant frequency or duration conditions. It is also significant to note the 833 
differences in children’s responses with respect to outcome measures (43%, word definition 834 
versus 86%, word naming). Within word learning studies alone, outcomes can include forced 835 
choice comprehension probes; naming; word definition; and synonym comprehension or 836 
production tasks; all of which may use experimental or unfamiliar referents and which can 837 
occur during intervention, immediately after or following a consolidation period. If we are to 838 
build the necessary evidence upon which to base clinical decisions the use of consistent 839 
outcome measures will be required to make meaningful cross study comparisons. In addition 840 
the timing of outcome measures is central to how we interpret study findings. This is 841 
highlighted in the work reported by Storkel and colleagues (2019), in which there was a 40% 842 
drop in word learning a mere 5 to 6 days post intervention.  843 
Based on the findings of their earlier study (2017) and reinforced by this most recent study 844 
(2019), when measured with a naming or word definition task, 36-word exposures appear to 845 
be the optimal dose for word learning in 5-6-year-old children with DLD. However, this age 846 
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range is narrow, and it would be interesting to investigate a potential interaction between age 847 
and number of exposures: an interaction revealed by Siegmüller and colleagues (2017) in 848 
relation to morphosyntax outcomes.  Finally, it is important to consider the interaction between 849 
dose and dose form. There is some evidence suggesting that increasing object variability (how 850 
a referent is presented) may result in word learning at a lower dose (see Aguilar et al., 2018) 851 
and this would seem a fruitful avenue for further research. 852 
Research examining dose frequency effects in word learning interventions in children with 853 
DLD, is also scarce.  This is despite the number of papers in the general verbal learning 854 
literature suggesting an advantage for distributed over massed learning (see meta-analysis 855 
completed by Janiszewski et al. (2003)). Although Riches and colleagues addressed this in their 856 
2005 paper,  as we have already noted, there was no blinding of outcomes; only four verbs 857 
were included in the study; and there were only two intervals of learning. In addition, both the 858 
massed and the spaced learning intervals were relatively concentrated i.e. the spaced condition 859 
was over 4 days, rather than a period of weeks as in the Storkel et al., (2017) paper and in much 860 
clinical practice. Recent work by Storkel and colleagues (2019) manipulating dose and dose 861 
frequency sheds further light on this topic, in that a much larger set of words were taught; there 862 
was some blinding of outcomes; and outcome measures were taken 21 as well as 5 days post 863 
intervention. Interestingly, when overall dose was controlled, the spacing of the treatment 864 
schedule did not impact children’s word-learning outcomes and the authors concluded that 865 
when treatment is given over a period of weeks, overall dose is more important than the 866 
frequency of the treatment schedule.  In this study the massed condition was over a period of 867 
4 weeks (x9 doses) and the spaced condition was for 9 weeks (x4 doses). However, how spaced 868 
and massed learning conditions are defined is problematic throughout the language learning 869 
literature.  One study’s ‘spaced’ presentation is another study’s ‘massed’ and there is 870 
significant variation in the total intervention duration and the total intervention hours 871 
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implemented. Future work is clearly required to ascertain what is optimal dosage for children 872 
with DLD. We recommend the systematic examination of a broad range of learning intervals 873 
across a range of ages together with a consideration of how those learning intervals interact 874 
with number of exposures.  875 
Morphosyntax: Although quantitative aspects of dosage have been more extensively studied in 876 
morphosyntax, it is revealing that only two studies investigated the effect of dose in 877 
interventions for children with DLD. Each study investigated a different dose subcomponent 878 
(the average rate of teaching episodes per unit of time; and the distribution of episodes within 879 
the session). Examination of dose frequency would suggest that where dose is high then dose 880 
frequency can be reduced (e.g. Balthazar & Scott, 2018). However the optimal dose per session 881 
has not yet been identified. Following dose manipulation through the presentation of recasts in 882 
low (.19 per minute) and high (.47 per minute) density conditions, Proctor-Williams and Fey 883 
(2007) reported no improvement in irregular past tense production accuracy in the high density 884 
condition. This paper is a telling example of the complex interactive nature of dosage and 885 
shows the difficulty involved in manipulating one aspect at a time. While cumulative 886 
intervention intensity was equivalent across groups and children’s expressive dose was equal 887 
in both density conditions (such that the manipulation was only with respect to the number of 888 
recasts children heard), the authors operationalised the manipulation of dose by significantly 889 
impacting dose frequency. In addition, total intervention duration was uncontrolled and very 890 
variable (4-44 days). There is an important gap in the evidence with studies needed taking a 891 
systematic approach to the examination of dose with respect to morphosyntax interventions. 892 
One such study was carried out by Plante and colleagues (2019). High dose recast density was 893 
manipulated within sessions, while at the same time controlling for dose, dose frequency and 894 
overall intervention duration. The high dose resulted in a treatment effect but no differences 895 
emerged as a result of the density with which the dose was given. Because other aspects of 896 
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dosage were controlled we can be clearer about conclusions drawn from this study. However 897 
the number of participants per group was small ( n = 10). The findings suggest that within-898 
session dose may be more important than the session length in which the doses are given 899 
however to increase confidence in this result replication is required with a larger sample. 900 
Potentially, this has important implications for therapists, many of whom have large caseloads, 901 
who may be able to deliver high dose effective morphosyntax interventions while allocating 902 
shorter time periods per session.  903 
In addition, an escalation design as implemented by Storkel and colleagues (2017) for 904 
vocabulary has the potential to be informative for morphosyntax, while controlling for dose 905 
frequency. In clinical practice, dose is rarely operationalised and measured. When considering 906 
dosage characteristics clinicians use proxy measures such as the number of intervention hours 907 
given over a specific period of time; the ratio of clinicians to children in an intervention service; 908 
and the degree of parent or child participation in a service over time. Without measurement of 909 
dose these can only ever yield rough approximations of dosage characteristics. 910 
Bellon-Harn and colleagues (2014) found tentative evidence that gains in morphosyntax in a 911 
narrative context can be achieved in a much shorter total intervention duration, when dose 912 
frequency is relatively intense. Unfortunately, due to the small sample size and no information 913 
on dose the study sheds little light on why almost double the number of sessions over a longer 914 
intervention duration offered no further advantage. We suggest that in keeping with deficient-915 
processing theories of learning (Cepeda et al., 2006) children’s focus may decrease when 916 
cumulative intervention intensity becomes too high. 917 
Lastly, dose frequency is the aspect of dosage most commonly examined in the morphosyntax 918 
domain and much of the discussion with respect to dose frequency centres around the concepts 919 
of concentrated versus distributed learning. Study findings are mixed and in keeping with our 920 
conclusions in relation to vocabulary, cross-study comparisons are difficult due to variation in 921 
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many study characteristics. In particular, the inconsistency with which the terms distributed 922 
and concentrated are defined is problematic. While findings by Smith Lock et al. (2013) and 923 
Siegmüller et al. (2017) support a distributed learning advantage, Bellon-Harn (2012), Meyers-924 
Denman et al. (2016) and Balthazar and Scott (2018) found no differences in the effect of 925 
treatment for concentrated versus distributed conditions.  However, sample sizes were 926 
particularly small in two of the three studies in which no differences were detected and 927 
therefore may obfuscate the true result. It is also worth noting that in both papers that report a 928 
distributed learning advantage, we are given no information on dose. In contrast, two of the 929 
three studies reporting no differences between conditions (Meyers-Denman et al., 2016; 930 
Balthazar and Scott (2018) control carefully for the effect of dose. Treatment dose was also 931 
very high in each study (24 recasts per day at a rate of one every 1.25 minutes; 26 or 28 sentence 932 
stimuli per session respectively). Interestingly, both studies also controlled for total 933 
intervention duration. In summary the research to date suggests no difference in a 934 
morphosyntax treatment effect between concentrated and distributed conditions if the 935 
treatment dose, rate of delivery, total treatment hours and total intervention duration, are 936 
controlled. In addition, one study has shown that if the rate of delivery within session is 937 
manipulated (massed versus distributed) no learning advantage emerges (Plante et al., 2019) 938 
However significantly more research is required with respect to concentrated and distributed 939 
intervention schedules and optimal dose frequency relative to dose, has yet to be established.  940 
Omnibus Outcomes: Insights regarding the interaction between dose and dose frequency have 941 
been gained from the two included papers which measure global language outcomes, where 942 
dose was defined as the amount of time spent on a given language target. Findings suggest that 943 
the best outcomes are achieved when children receive either ‘little and often’: frequent sessions 944 
(~ 3 times per week) in which the focus on a specific language target is very short (2 minutes) 945 
; or ‘more and less often’: less frequent sessions (~ weekly)  in which specific goals are targeted 946 
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for longer periods (20 minutes). The evidence for ‘little and often’, if embedded within longer 947 
sessions with mixed goals, may be confounded by an increase in variability and intervention 948 
context. By changing the target after two minutes, both variability and context change, both of 949 
which are thought to be advantageous to children’s language learning, (Haebig et al., 2019; 950 
Plante et al., 2014). What is unclear is how many times (or if at all) the target was revisited 951 
within a single session, i.e. whether there was a within session spacing effect.  In the ‘more, 952 
less often’ scenario there is greater spacing between sessions which may have been a 953 
facilitating factor in increasing learning. More work is required to illuminate what is driving 954 
these effects.  955 
Summary and Recommendations for the future 956 
This review highlights the limited research base available from which to identify optimal 957 
quantitative dosage characteristics in the domains of phonology, vocabulary and 958 
morphosyntax. The need for future research to inform clinical practice is significant. Dosage 959 
characteristics and their interactions in speech and language therapy are complex. To 960 
summarise what has been reported to date, more is not always better, and studies show a point 961 
of diminishing returns for both vocabulary (number of exposures) and morphosyntax 962 
(frequency/ total number of intervention sessions). There is some evidence suggesting that 963 
younger children may require fewer sessions to achieve the same results (in relation to 964 
morphosyntax) but dose frequency and total intervention duration have not been systematically 965 
examined in relation to age and dose form techniques were not accounted for in this finding. 966 
Study findings also suggest that if dose is high (the number of learning opportunities within a 967 
session) then frequency can be reduced, particularly in relation to morphosyntax. Although 968 
results suggest no spaced learning advantage between sessions (for morphosyntax) if all other 969 
dosage characteristics are controlled, inconsistencies in the definitions of spaced/distributed 970 
and massed/concentrated have been problematic, making cross-study comparison and clinical 971 
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application difficult. Within session spacing has been under-researched and while Plante and 972 
colleagues (2019) report no differences in treatment effects based on the within session density 973 
with which the dose was given, changes in dose form context which inadvertently create within 974 
session spacing have been found to be advantageous (Haebig et al., 2019).  Finally, frequent 975 
interventions (2/3 times per week) that target language goals for short periods, or less frequent 976 
interventions (1 per week or fortnight) targeting language goals for longer, have been found to 977 
yield the best outcomes in relation to composite language measures. However, more nuanced 978 
research is required to examine the facilitators of these effects. 979 
Although there are clear gaps in the evidence some implications for practice arise from this 980 
review. Findings from Schmitt et al. (2016) and Justice et al. (2017) support the current practice 981 
of weekly or fortnightly sessions as an efficient model but only if dose is high. Ensuring 982 
intervention sessions contain high levels of the ‘active ingredients’ of interventions is therefore 983 
vital. Furthermore ‘little and often’ practice would also seem to be supported as being a 984 
potentially effective approach. Such intervention schedules are often more accessible to parents 985 
and educational practitioners working in partnership with SLPs. However, efficacy would 986 
depend on appropriate treatment fidelity such that the dose form delivers the necessary active 987 
ingredients of the intervention. This review also demonstrates that there are minimum 988 
cumulative interventions dosages required for children’s performance to improve on 989 
intervention goals and also that too many may bring diminishing returns. Whilst the review has 990 
not been able to identify a ‘magic number’ for success it does suggest that simply delivering 991 
the number of intervention hours which are part of local custom and practice is not defensible. 992 
Rather to ensure dosage is sufficient to have an effect, children’s progress should be monitored 993 
over the course of therapy and delivered until a child reaches a pre-determined criterion of 994 
success, and to ensure resources aren’t wasted, the focus of an intervention should be changed 995 
when progress plateaus. The implications for research are clear. A systematic program of 996 
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studies is required which manipulate individual dosage characteristics whilst keeping others 997 
constant. The potential to leverage spacing effects to maximise efficiency appears promising, 998 
but more work is needed. We recommend the development of a minimum data set of agreed 999 
outcome measures across the discipline together with the more widespread adoption of open 1000 
data practices. This would allow data pooling and meta-analyses to be conducted enabling the 1001 
consideration of the relative contribution of different dosage characteristics on intervention 1002 
effects and so identify the optimal dosage characteristics with which to efficiently, effectively 1003 
and ethically intervene to make a difference to the lives of individuals with DLD.   1004 
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Table 1. Summary of included intervention studies, with vocabulary, phonology or morphosyntax outcomes, in which aspects of dose frequency were manipulated. 
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Search strategy for “Systematic reviews of interventions aimed at the 
vocabulary, morpho-syntax and phonology of children with 
Developmental Language Disorder within the COST IS1406 network”  
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"developmental communication disorder") AND (child* OR preschool* OR adolescen* OR teenage* 
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Web of Science  
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difficulties" OR disease ) ) AND SUBJAREA ( mult OR medi OR nurs OR vete OR dent OR heal OR mult 
OR arts OR busi OR deci OR econ OR psyc OR soci ) AND PUBYEAR > 2005 AND PUBYEAR < 2016 AND 
















PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: recommended items to 
address in a systematic review protocol*  
Section and topic Item No Checklist item 
ADMINISTRATIVE INFORMATION 
Title:   
 Identification 1a Identify the report as a protocol of a systematic review 
 Update 1b If the protocol is for an update of a previous systematic review, identify as such 
Registration 2 If registered, provide the name of the registry (such as PROSPERO) and registration number 
Authors:   
 Contact 3a Provide name, institutional affiliation, e-mail address of all protocol authors; provide physical mailing address of 
corresponding author 
 Contributions 3b Describe contributions of protocol authors and identify the guarantor of the review 
Amendments 4 If the protocol represents an amendment of a previously completed or published protocol, identify as such and list 
changes; otherwise, state plan for documenting important protocol amendments 
Support:   
 Sources 5a Indicate sources of financial or other support for the review 
 Sponsor 5b Provide name for the review funder and/or sponsor 
 Role of sponsor or funder 5c Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol 
INTRODUCTION 












Objectives 7 Provide an explicit statement of the question(s) the review will address with reference to participants, interventions, 
comparators, and outcomes (PICO) 
METHODS 
Eligibility criteria 8 Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years 
considered, language, publication status) to be used as criteria for eligibility for the review 
Information sources 9 Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or 
other grey literature sources) with planned dates of coverage 
Search strategy 10 Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it 
could be repeated 
Study records:   
 Data management 11a Describe the mechanism(s) that will be used to manage records and data throughout the review 
 Selection process 11b State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the 
review (that is, screening, eligibility and inclusion in meta-analysis) 
 Data collection process 11c Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any 
processes for obtaining and confirming data from investigators 
Data items 12 List and define all variables for which data will be sought (such as PICO items, funding sources), any pre-planned data 
assumptions and simplifications 
Outcomes and prioritization 13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with 
rationale 
Risk of bias in individual studies 14 Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the 
outcome or study level, or both; state how this information will be used in data synthesis 
Data synthesis 15a Describe criteria under which study data will be quantitatively synthesised 
15b If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data and 












15c Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression) 
15d If quantitative synthesis is not appropriate, describe the type of summary planned 
Meta-bias(es) 16 Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within 
studies) 
Confidence in cumulative evidence 17 Describe how the strength of the body of evidence will be assessed (such as GRADE) 
* It is strongly recommended that this checklist be read in conjunction with the PRISMA-P Explanation and Elaboration (cite when available) for important 
clarification on the items. Amendments to a review protocol should be tracked and dated. The copyright for PRISMA-P (including checklist) is held by the 
PRISMA-P Group and is distributed under a Creative Commons Attribution Licence 4.0.  
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